Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings

Frontiers in Immunology(2020)10.3389/fimmu.2020.01958Source: DataRank Database

Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.06)OA: goldTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Anil Shanker ORCID,Mikhail M. Dikov,David P. Carbone ORCID,Mounika Goruganthu

Live enrichment

PubMed:32922403 PMC:PMC7456812 OpenAlex:https://openalex.org/W3049354786

NCI NIH HHS

Grant: R01 CA138923

NCI NIH HHS

Grant: SC1 CA182843

NCI NIH HHS

Grant: R01 CA175370

NCI NIH HHS

Grant: U54 CA091408

NCI NIH HHS

Grant: U54 CA163069

FWCI

1.06

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.01958/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.01958/pdf

publisherhttps://www.frontiersin.org/article/10.3389/fimmu.2020.01958/full

journalhttps://doi.org/10.3389/fimmu.2020.01958

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32922403

Fields of Study

Cancer Cells and MetastasisDevelopmental Biology and Gene RegulationT-cell and B-cell Immunology

MeSH Terms

AnimalsAntineoplastic AgentsHumansLigandsNeoplasmsSignal TransductionImmunotherapy, AdoptiveLymphocytes, Tumor-InfiltratingTumor EscapeReceptors, NotchMolecular Targeted TherapyTumor Microenvironment

Keywords

Notch signaling pathwayEffectorImmune systemCancerImmunologyMedicineImmunotherapyLigand (biochemistry)NeuroscienceCancer researchReceptorBiologySignal transductionCell biologyInternal medicineAntigen presenting cellsT cellsNotch signalingCancer ImmunotherapyTumor escapeImmunosurveillanceEngineered Notch LigandsNotch Therapeutics

Sustainable Development Goals

SDG 0: Good health and well-being

Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings

FAIR Checklist

Authors (4)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)